C12N 2795/10333
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2795/10333 (Use of viral protein as therapeutic agent other than vaccine) appears on 9 US grants and 14 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 14
- Assignees
- 13
- Inventors
- 40
- Latest grant
- 11 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 2 |
| 2020 | 0 | 2 |
| 2021 | 1 | 1 |
| 2022 | 2 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of treating pathogenic bacterial infectious diseases11 Feb 2025US 12,220,448 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Immunogenic sequences from a phage tail length tape measure protein, bacteria expressing the same and their use in treating a cancer1 Oct 2024US 12,102,672 B2Centre Hospitalier Universitaire De Rennes
- Antibacterial protein EFAL-2 having bacteriolytic ability with respect to Enterococcus faecium8 Nov 2022US 11,492,378 B2Intron Biotechnology, Inc.
- Vibrio anguillarum bacteriophage VIB-ANP-1 and use thereof for inhibiting proliferation of Vibrio anguillarum bacteria13 Sep 2022US 11,439,677 B2Intron Biotechnology, Inc.
- Bacteriophage and composition comprising same23 Feb 2021US 10,925,909 B2Cj Cheiljedang Corporation
- Bacteriophages as a tool to manipulate gut commensal immune-modulation activity17 Sep 2026US 2026/0273002 A1Technion Research & Development Foundation Limited
- Cancer eradicating - bio-nanoparticles (ce-bnp)2 Nov 2023US 2023/0346862 A1Athanor Biosciences, Inc.
- Phage-encoded acrvia1 for use as an inhibitor of the rna-targeting crispr-cas13 systems22 Jun 2023US 2023/0193409 A1
- Use of recombinant antibacterial enzyme lyssap26 effectively killing pathogenic bacteria9 Jun 2022US 2022/0175894 A1Kyungpook National University Industry-Academic Cooperation Foundation
- Novel antibacterial protein efal-2 having bacteriolytic ability with respect to enterococcus faecium11 Mar 2021US 2021/0070809 A1Intron Biotechnology, Inc.
Most cited
By later US patents